Meta-Analysis of Candidate Surrogate End Points in Advanced Prostate Cancer

NEJM Evid. 2023 Apr;2(4):EVIDoa2200195. doi: 10.1056/EVIDoa2200195. Epub 2023 Mar 27.

Abstract

Meta-Analysis of Surrogate End Points in Prostate CancerGharzai et al. report on the results of a meta-analysis, which concludes that unlike the case in localized prostate cancer, surrogate end points in advanced prostate cancer may not track overall survival.

Publication types

  • Meta-Analysis

MeSH terms

  • Biomarkers
  • Humans
  • Male
  • Prostate
  • Prostatic Neoplasms*

Substances

  • Biomarkers